In particular, by using the citrulline/Arg ratio as an index of NO levels and NOS activity, they found that the citrulline/Arg ratio was significantly higher in the MS group compared to the controls, according to the current literature [109,110], along with serum ADMA levels. The gene discussed is NOS2; the disease is myeloid sarcoma.